Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists.
about
FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIPMonoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published EvidenceAccelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients' Satisfaction and Cost Analysis. A Cohort Study in IBD Patients.Molecular modeling of antibodies for the treatment of TNFα-related immunological diseases.Interleukin-13 interferes with activation-induced t-cell apoptosis by repressing p53 expression.TNF-α receptor antagonist attenuates isoflurane-induced cognitive impairment in aged rats.
P2860
Apoptosis and the FLIP and NF-kappa B proteins as pharmacodynamic criteria for biosimilar TNF-alpha antagonists.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Apoptosis and the FLIP and NF- ...... similar TNF-alpha antagonists.
@en
type
label
Apoptosis and the FLIP and NF- ...... similar TNF-alpha antagonists.
@en
prefLabel
Apoptosis and the FLIP and NF- ...... similar TNF-alpha antagonists.
@en
P2860
P356
P1476
Apoptosis and the FLIP and NF- ...... similar TNF-alpha antagonists.
@en
P2093
Valderilio Feijó Azevedo
P2860
P304
P356
10.2147/BTT.S57253
P577
2014-07-31T00:00:00Z